Erratum: Adipose tissue-derived mesenchymal stem cells in long-term dialysis patients display downregulation of PCAF expression and poor angiogenesis activation (PLoS ONE (2014) 9:7 (e102311) DOI: 10.1371/journal.pone.0102311);Adipose tissue-derived mesenchymal stem cells in long-term dialysis patients display downregulation of PCAF expression and poor angiogenesis activation

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Yamanaka, Shuichiro ^a   Yokote, Shinya ^a   Yamada, Akifumi ^a   Katsuoka, Yuichi ^a   Izuhara, Luna ^a   Shimada, Yohta ^a   Omura, Nobuo ^a   Okano, Hirotaka James ^a   Ohki, Takao ^a   Yokoo, Takashi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE PCAF; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN; P300-CBP-ASSOCIATED FACTOR;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ANGIOGENESIS; ARTICLE; CARTILAGE CELL; CELL AGING; CELL HYPOXIA; CELL ISOLATION; CELL PROLIFERATION; CELL VIABILITY; CHRONIC PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; END STAGE RENAL DISEASE; FEMALE; GENE EXPRESSION REGULATION; HIF 1ALPHA GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MESENCHYMAL STEM CELL; MIDDLE AGED; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PCAF GENE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RENAL REPLACEMENT THERAPY; UREMIA; VEGF GENE; WESTERN BLOTTING; CASE CONTROL STUDY; CYTOLOGY; DOWN REGULATION; MESENCHYMAL STROMA CELL; METABOLISM; NEOVASCULARIZATION (PATHOLOGY);

ADIPOSE TISSUE; ADULT; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; P300-CBP TRANSCRIPTION FACTORS; RENAL DIALYSIS;

EID: 84904266057     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0157282     Document Type: Erratum

References (42)

1. The Japanese Society of Nephrology (2012) Clinical practice guidebook for diagnosis and treatment of chronic kidney disease. Jpn J Nephrol 54: 1031-1189.
2. Berger A, Edelsberg J, Inglese GW, Bhatttacharyya SK, Oster G (2009) Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease. Am J Manag Care 15: 509-518.
3. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, et al. (1999) Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a fiomp cadaveric transplant. N Engl J Med 341: 1725-1730.
4. Sonoda T, Takahara S, Takahashi K, Uchida K, Ohshima S, et al. (2003) Outcome of 3 years of immunosuppression with tacrolimus in more than 1,000 renal transplant recipients in Japan. Transplantation 75: 1999-024.
5. Badylak SF, Taylor D, Uygun K (2011) Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng 15: 27-53.
6. Xinaris C, Benedetti V, Rizzo P, Abbate M, Corna D, et al. (2012) In vivo maturation of functional renal organoids formed from embryonic cell suspensions. J Am Soc Nephrol 23: 1857-1868.
7. Yokoo T, Ohashi T, Shen JS, Sakurai K, Miyazaki Y, et al. (2005) Human mesenchymal stem cells in rodent whole embryo culture are reprogrammed to contribute kidney tissues. Proc Natl Acad Sci U S A 102: 3296-3300. (Pubitemid 40328039)
8. Yokoo T, Fukui A, Ohashi T, Miyazaki Y, Utsunomiya Y, et al. (2006) Xenobiotic kidney organogenesis from human mesenchymal stem cells using a growing rodent embryo. J Am Soc Nephrol 17: 1026-1034.
9. Yokoo T, Fukui A, Matsumoto K, Ohashi T, Sado Y, et al. (2008) Generation of transplantable erythropoietin producer derived from human mesenchymal stem cells. Transplantation 85: 1654-1658.
10. Aust L, Devlin B, Foster SJ, Halvorsen YD, Hicok K, et al. (2004) Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy 6: 7-14. (Pubitemid 38325114)
11. Gonzalez-Cruz RD, Fonseca VC, Darling EM (2012) Cellular mechanical properties reflect the differentiation potential of adipose-derived mesenchymal stem cells. Proc Natl Acad Sci U S A 12: E1523-1529.
12. Drewa T, Joachimiak R, Kaznica A, Flisinski M, Brymora A, et al. (2008) Bone marrow progenitors from animals with chronic renal failure lack capacity of in vitro proliferation. Transplant Proc 40: 1668-1673. (Pubitemid 351853187)
13. Noh H, Yu MR, Kim HJ, Jeon JS, Kwon SH, et al. (2012) Uremia induces functional incompetence of bone marrow-derived stromal cells. Nephrol Dial Transplant 27: 218-225.
14. Roemeling-van Rhijn M, Reinders ME, de Klein A, Douben H, Korevaar SS, et al. (2012) Mesenchymal stem cells derived from adipose tissue are not affected by renal disease. Kidney Int 82: 748-758.
15. Yamada A, Yokoo T, Yokote S, Yamanaka S, Izuhara L, et al. (2014) Comparison of multipotency and molecular profile of MSCs between CKD and healthy rats. Hum Cell 27: 59-67.
16. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, et al. (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228. (Pubitemid 32295155)
17. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, et al. (2007) Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 46: 219-228. (Pubitemid 47171939)
18. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317. (Pubitemid 44269669)
19. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, et al. (2008) Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 3: e2213.
20. Huang J, Gan Q, Han L, Li J, Zhang H, et al. (2008) SIRT1 overexpression antagonizes cellular senescence with activated ERK/S6k1 signaling in human diploid fibroblasts. PLoS One 5: e1710.
21. Nekanti U, Dastidar S, Venugopal P, Totey S, Ta M (2010) Increased proliferation and analysis of differential gene expression in human Wharton's jelly-derived mesenchymal stromal cells under hypoxia. Int J Biol Sci 9: 499-512.
22. Shimada Y, Nishida H, Nishiyama Y, Kobayashi H, Higuchi T, et al. (2011) Proteasome inhibitors improve the function of mutant lysosomal α-glucosidase in fibroblasts from Pompe disease patient carrying c.546G>T mutation. Biochem Biophys Res Commun 415: 274-278.
23. Sahagun G, Moore SA, Fabry Z, Schelper RL, Hart MN (1989) Purification of murine endothelial cell cultures by flow cytometry using fluorescein-labeled griffonia simplicifolia agglutinin. Am J Pathol 134: 1227-32. (Pubitemid 19206309)
24. Basile JR, Holmbeck K, Bugge TH, Gutkind JS (2007) MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. J Biol Chem 2: 6899-905. (Pubitemid 47100895)
25. Narita M, Nũnez S, Heard E, Narita M, Lin AW, et al. (2003) Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 13: 703-16. (Pubitemid 36724935)
26. Okuyama H, Krishnamachary B, Zhou YF, Nagasawa H, Bosch-Marce M, et al. (2006) Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1. J Biol Chem 281: 15554-15563. (Pubitemid 43855148)
27. Bastiaansen AJ, Ewing MM, de Boer HC, van der Pouw Kraan TC, de Vries MR, et al. (2013) Lysine acetyltransferase PCAF is a key regulator of arteriogenesis. Arterioscler Thromb Vasc Biol 33: 1902-1910.
28. Guedez L, Rivera AM, Salloum R, Miller ML, Diegmueller JJ, et al. (2003) Quantitative assessment of angiogenic response by the Directed In Vivo Angiogenesis Assay. American J Pathol 162: 1431-1439. (Pubitemid 36512825)
29. Xenaki G, Ontikatze T, Rajendran R, Stratford IJ, Dive C, et al. (2008) PCAF is an HIF-1alpha cofactor that regulates p53 transcriptional activity in hypoxia. Oncogene 27: 5785-5796.
30. Ravnskjaer K, Hogan MF, Lackey D, Tora L, Dent SY, et al. (2013) Glucagon regulates gluconeogenesis through KAT2B- and WDR5-mediated epigenetic effects. J Clin Invest 123: 4318-4328.
31. Ferrari R, Pellegrini M, Horwitz GA, Xie W, Berk AJ, et al. (2008) Epigenetic reprogramming by adenovirus e1a. Science 321: 1086-1088.
32. Pillai S, Kovacs M, Chellappan S (2010) Regulation of vascular endothelial growth factor receptors by Rb and E2F1: role of acetylation. Cancer Res 70: 4931-4940.
33. Lim JH, Lee YM, Chun YS, Chen J, Kim JE, et al. (2010) Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell 38: 864-878.
34. Jin Y, Zeng SX, Dai MS, Yang X-J, Lu H (2002) MDM2 inhibits PCAF-mediated p53 acetylation. J Biol Chem 277: 30838-30843.
35. Linares LK, Kiernan R, Triboulet R, Chable-Bessia C, Latreille D, et al. (2007) Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2. Nat Cell Biol 9: 331-338. (Pubitemid 46344613)
36. Kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z, et al. (2003) Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93: 1074-1081. (Pubitemid 37485038)
37. Shakib K, Norman JT, Fine LG, Brown LR, Godovac-Zimmermann J (2005) Proteomics profiling of nuclear proteins for kidney fibroblasts suggests hypoxia, meiosis, and cancer may meet in the nucleus. Proteomics 5: 2819-2838. (Pubitemid 41059760)
38. Martínez-Balbás MA, Bauer UM, Nielsen SJ, Brehm A, Kouzarides T (2000) Regulation of E2F1 activity by acetylation. EMBO J 19: 662-671. (Pubitemid 30093739)
39. Meyer TW, Hostetter TH (2007) Uremia. N Engl J Med 27: 1316-1325.
40. Bernhardt WM, Schmitt R, Rosenberger C, Munchenhagen PM, Grone HJ, et al. (2006) Expression of hypoxia-inducible transcription factors in developing human and rat kidneys. Kidney Int 69: 114-122. (Pubitemid 43117746)
41. Bechtel-Walz W, Huber TB (2014) Chromatin dynamics in kidney development and function. Cell Tissue Res 356: 601-608
42. Chen S, Bellew C, Yao X, Stefkova J, Dipp S, et al. (2011) Histone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiation. J Biol Chem 286: 32775-32789.